Global Age Related Macular Degeneration Drug Market Research Report Forecast 2017-2021 Chapter 1 Age Related Macular Degeneration Drug Market Overview 1.1 Product Overview and Scope of Age Related Macular Degeneration Drug 1.2 Age Related Macular Degeneration Drug Market Segmentation by Type 1.2.1 Global Production Market Share of Age Related Macular Degeneration Drug by Type in 2015 1.2.1 Type 1 1.2.2 Type 2 1.2.3 Type 3 1.3 Age Related Macular Degeneration Drug Market Segmentation by Application 1.3.1 Age Related Macular Degeneration Drug Consumption Market Share by Application in 2015 1.3.2 Application 1 1.3.3 Application 2 1.3.4 Application 3 1.4 Age Related Macular Degeneration Drug Market Segmentation by Regions 1.4.1 North America 1.4.2 China 1.4.3 Europe 1.4.4 Southeast Asia 1.4.5 Japan 1.4.6 India 1.5 Global Market Size (Value) of Age Related Macular Degeneration Drug (2012-2021) Chapter 2 Global Economic Impact on Age Related Macular Degeneration Drug Industry 2.1 Global Macroeconomic Environment Analysis 2.1.1 Global Macroeconomic Analysis 2.1.2 Global Macroeconomic Environment Development Trend 2.2 Global Macroeconomic Environment Analysis by Regions Chapter 3 Global Age Related Macular Degeneration Drug Market Competition by Manufacturers 3.1 Global Age Related Macular Degeneration Drug Production and Share by Manufacturers (2015 and 2016) 3.2 Global Age Related Macular Degeneration Drug Revenue and Share by Manufacturers (2015 and 2016) 3.3 Global Age Related Macular Degeneration Drug Average Price by Manufacturers (2015 and 2016) 3.4 Manufacturers Age Related Macular Degeneration Drug Manufacturing Base Distribution, Production Area and Product Type 3.5 Age Related Macular Degeneration Drug Market Competitive Situation and Trends 3.5.1 Age Related Macular Degeneration Drug Market Concentration Rate 3.5.2 Age Related Macular Degeneration Drug Market Share of Top 3 and Top 5 Manufacturers 3.5.3 Mergers & Acquisitions, Expansion Chapter 4 Global Age Related Macular Degeneration Drug Production, Revenue (Value) by Region (2012-2017) 4.1 Global Age Related Macular Degeneration Drug Production by Region (2012-2017) 4.2 Global Age Related Macular Degeneration Drug Production Market Share by Region (2012-2017) 4.3 Global Age Related Macular Degeneration Drug Revenue (Value) and Market Share by Region (2012-2017) 4.4 Global Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) 4.5 North America Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) 4.6 Europe Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) 4.7 China Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) 4.8 Japan Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) 4.9 Southeast Asia Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) 4.10 India Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) Chapter 5 Global Age Related Macular Degeneration Drug Supply (Production), Consumption, Export, Import by Regions (2012-2017) 5.1 Global Age Related Macular Degeneration Drug Consumption by Regions (2012-2017) 5.2 North America Age Related Macular Degeneration Drug Production, Consumption, Export, Import by Regions (2012-2017) 5.3 Europe Age Related Macular Degeneration Drug Production, Consumption, Export, Import by Regions (2012-2017) 5.4 China Age Related Macular Degeneration Drug Production, Consumption, Export, Import by Regions (2012-2017) 5.5 Japan Age Related Macular Degeneration Drug Production, Consumption, Export, Import by Regions (2012-2017) 5.6 Southeast Asia Age Related Macular Degeneration Drug Production, Consumption, Export, Import by Regions (2012-2017) 5.7 India Age Related Macular Degeneration Drug Production, Consumption, Export, Import by Regions (2012-2017) Chapter 6 Global Age Related Macular Degeneration Drug Production, Revenue (Value), Price Trend by Type 6.1 Global Age Related Macular Degeneration Drug Production and Market Share by Type (2012-2017) 6.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Type (2012-2017) 6.3 Global Age Related Macular Degeneration Drug Price by Type (2012-2017) 6.4 Global Age Related Macular Degeneration Drug Production Growth by Type (2012-2017) Chapter 7 Global Age Related Macular Degeneration Drug Market Analysis by Application 7.1 Global Age Related Macular Degeneration Drug Consumption and Market Share by Application (2012-2017) 7.2 Global Age Related Macular Degeneration Drug Consumption Growth Rate by Application (2012-2017) 7.3 Market Drivers and Opportunities 7.3.1 Potential Applications 7.3.2 Emerging Markets/Countries Chapter 8 Global Age Related Macular Degeneration Drug Manufacturers Analysis 8.1 Roche/Genentech 8.1.1 Company Basic Information, Manufacturing Base and Competitors 8.1.2 Product Type, Application and Specification 8.1.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.1.4 Business Overview 8.2 Novartis 8.2.1 Company Basic Information, Manufacturing Base and Competitors 8.2.2 Product Type, Application and Specification 8.2.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.2.4 Business Overview 8.3 Regeneron 8.3.1 Company Basic Information, Manufacturing Base and Competitors 8.3.2 Product Type, Application and Specification 8.3.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.3.4 Business Overview 8.4 Bayer 8.4.1 Company Basic Information, Manufacturing Base and Competitors 8.4.2 Product Type, Application and Specification 8.4.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.4.4 Business Overview 8.5 Valeant 8.5.1 Company Basic Information, Manufacturing Base and Competitors 8.5.2 Product Type, Application and Specification 8.5.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.5.4 Business Overview 8.6 Allergan 8.6.1 Company Basic Information, Manufacturing Base and Competitors 8.6.2 Product Type, Application and Specification 8.6.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.6.4 Business Overview 8.7 Alimera Sciences 8.7.1 Company Basic Information, Manufacturing Base and Competitors 8.7.2 Product Type, Application and Specification 8.7.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.7.4 Business Overview 8.8 Ophthotech 8.8.1 Company Basic Information, Manufacturing Base and Competitors 8.8.2 Product Type, Application and Specification 8.8.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.8.4 Business Overview 8.9 Acucela 8.9.1 Company Basic Information, Manufacturing Base and Competitors 8.9.2 Product Type, Application and Specification 8.9.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.9.4 Business Overview … Chapter 9 Age Related Macular Degeneration Drug Manufacturing Cost Analysis 9.1 Age Related Macular Degeneration Drug Key Raw Materials Analysis 9.1.1 Key Raw Materials 9.1.2 Price Trend of Key Raw Materials 9.1.3 Key Suppliers of Raw Materials 9.1.4 Market Concentration Rate of Raw Materials 9.2 Proportion of Manufacturing Cost Structure 9.2.1 Raw Materials 9.2.2 Labor Cost 9.2.3 Manufacturing Expenses 9.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug Chapter 10 Industrial Chain, Sourcing Strategy and Downstream Buyers 10.1 Age Related Macular Degeneration Drug Industrial Chain Analysis 10.2 Upstream Raw Materials Sourcing 10.3 Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2015 10.4 Downstream Buyers Chapter 11 Marketing Strategy Analysis, Distributors/Traders 11.1 Marketing Channel 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Development Trend 11.2 Market Positioning 11.2.1 Pricing Strategy 11.2.2 Brand Strategy 11.2.3 Target Client 11.3 Distributors/Traders List Chapter 12 Market Effect Factors Analysis 12.1 Technology Progress/Risk 12.1.1 Substitutes Threat 12.1.2 Technology Progress in Related Industry 12.2 Consumer Needs/Customer Preference Change 12.3 Economic/Political Environmental Change Chapter 13 Global Age Related Macular Degeneration Drug Market Forecast (2017-2021) 13.1 Global Age Related Macular Degeneration Drug Production, Revenue Forecast (2017-2021) 13.2 Global Age Related Macular Degeneration Drug Production, Consumption Forecast by Regions (2017-2021) 13.3 Global Age Related Macular Degeneration Drug Production Forecast by Type (2017-2021) 13.4 Global Age Related Macular Degeneration Drug Consumption Forecast by Application (2017-2021) 13.5 Age Related Macular Degeneration Drug Price Forecast (2017-2021) Chapter 14 Appendix

Figure Picture of Age Related Macular Degeneration Drug Figure Global Production Market Share of Age Related Macular Degeneration Drug by Type in 2015 Figure Product Picture of Type I Table Major Manufacturers of Type I Figure Product Picture of Type II Table Major Manufacturers of Type II Figure Product Picture of Type III Table Major Manufacturers of Type III Table Age Related Macular Degeneration Drug Consumption Market Share by Application in 2015 Figure Application 1 Examples Figure Application 2 Examples Figure Application 3 Examples Figure North America Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2021) Figure Europe Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2021) Figure China Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2021) Figure Japan Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2021) Figure Southeast Asia Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2021) Figure India Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2021) Figure Global Age Related Macular Degeneration Drug Revenue (Million UDS) and Growth Rate (2012-2021) Table Global Age Related Macular Degeneration Drug Capacity of Key Manufacturers (2015 and 2016) Table Global Age Related Macular Degeneration Drug Capacity Market Share by Manufacturers (2015 and 2016) Figure Global Age Related Macular Degeneration Drug Capacity of Key Manufacturers in 2015 Figure Global Age Related Macular Degeneration Drug Capacity of Key Manufacturers in 2016 Table Global Age Related Macular Degeneration Drug Production of Key Manufacturers (2015 and 2016) Table Global Age Related Macular Degeneration Drug Production Share by Manufacturers (2015 and 2016) Figure 2015 Age Related Macular Degeneration Drug Production Share by Manufacturers Figure 2016 Age Related Macular Degeneration Drug Production Share by Manufacturers Table Global Age Related Macular Degeneration Drug Revenue (Million USD) by Manufacturers (2015 and 2016) Table Global Age Related Macular Degeneration Drug Revenue Share by Manufacturers (2015 and 2016) Table 2015 Global Age Related Macular Degeneration Drug Revenue Share by Manufacturers Table 2016 Global Age Related Macular Degeneration Drug Revenue Share by Manufacturers Table Global Market Age Related Macular Degeneration Drug Average Price of Key Manufacturers (2015 and 2016) Figure Global Market Age Related Macular Degeneration Drug Average Price of Key Manufacturers in 2015 Table Manufacturers Age Related Macular Degeneration Drug Manufacturing Base Distribution and Sales Area Table Manufacturers Age Related Macular Degeneration Drug Product Type Figure Age Related Macular Degeneration Drug Market Share of Top 3 Manufacturers Figure Age Related Macular Degeneration Drug Market Share of Top 5 Manufacturers Table Global Age Related Macular Degeneration Drug Capacity by Regions (2012-2017) Figure Global Age Related Macular Degeneration Drug Capacity Market Share by Regions (2012-2017) Figure Global Age Related Macular Degeneration Drug Capacity Market Share by Regions (2012-2017) Figure 2015 Global Age Related Macular Degeneration Drug Capacity Market Share by Regions Table Global Age Related Macular Degeneration Drug Production by Regions (2012-2017) Figure Global Age Related Macular Degeneration Drug Production and Market Share by Regions (2012-2017) Figure Global Age Related Macular Degeneration Drug Production Market Share by Regions (2012-2017) Figure 2015 Global Age Related Macular Degeneration Drug Production Market Share by Regions Table Global Age Related Macular Degeneration Drug Revenue by Regions (2012-2017) Table Global Age Related Macular Degeneration Drug Revenue Market Share by Regions (2012-2017) Table 2015 Global Age Related Macular Degeneration Drug Revenue Market Share by Regions Table Global Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) Table North America Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) Table Europe Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) Table China Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) Table Japan Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) Table Southeast Asia Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) Table India Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) Table Global Age Related Macular Degeneration Drug Consumption Market by Regions (2012-2017) Table Global Age Related Macular Degeneration Drug Consumption Market Share by Regions (2012-2017) Figure Global Age Related Macular Degeneration Drug Consumption Market Share by Regions (2012-2017) Figure 2015 Global Age Related Macular Degeneration Drug Consumption Market Share by Regions Table North America Age Related Macular Degeneration Drug Production, Consumption, Import & Export (2012-2017) Table Europe Age Related Macular Degeneration Drug Production, Consumption, Import & Export (2012-2017) Table China Age Related Macular Degeneration Drug Production, Consumption, Import & Export (2012-2017) Table Japan Age Related Macular Degeneration Drug Production, Consumption, Import & Export (2012-2017) Table Southeast Asia Age Related Macular Degeneration Drug Production, Consumption, Import & Export (2012-2017) Table India Age Related Macular Degeneration Drug Production, Consumption, Import & Export (2012-2017) Table Global Age Related Macular Degeneration Drug Production by Type (2012-2017) Table Global Age Related Macular Degeneration Drug Production Share by Type (2012-2017) Figure Production Market Share of Age Related Macular Degeneration Drug by Type (2012-2017) Figure 2015 Production Market Share of Age Related Macular Degeneration Drug by Type Table Global Age Related Macular Degeneration Drug Revenue by Type (2012-2017) Table Global Age Related Macular Degeneration Drug Revenue Share by Type (2012-2017) Figure Production Revenue Share of Age Related Macular Degeneration Drug by Type (2012-2017) Figure 2015 Revenue Market Share of Age Related Macular Degeneration Drug by Type Table Global Age Related Macular Degeneration Drug Price by Type (2012-2017) Figure Global Age Related Macular Degeneration Drug Production Growth by Type (2012-2017) Table Global Age Related Macular Degeneration Drug Consumption by Application (2012-2017) Table Global Age Related Macular Degeneration Drug Consumption Market Share by Application (2012-2017) Figure Global Age Related Macular Degeneration Drug Consumption Market Share by Application in 2015 Table Global Age Related Macular Degeneration Drug Consumption Growth Rate by Application (2012-2017) Figure Global Age Related Macular Degeneration Drug Consumption Growth Rate by Application (2012-2017) Table Roche/Genentech Basic Information, Manufacturing Base, Production Area and Its Competitors Table Roche/Genentech Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) Table Roche/Genentech Age Related Macular Degeneration Drug Market Share (2012-2017) Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors Table Novartis Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) Table Novartis Age Related Macular Degeneration Drug Market Share (2012-2017) Table Regeneron Basic Information, Manufacturing Base, Production Area and Its Competitors Table Regeneron Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) Table Regeneron Age Related Macular Degeneration Drug Market Share (2012-2017) Table Bayer Basic Information, Manufacturing Base, Production Area and Its Competitors Table Bayer Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) Table Bayer Age Related Macular Degeneration Drug Market Share (2012-2017) Table Valeant Basic Information, Manufacturing Base, Production Area and Its Competitors Table Valeant Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) Table Valeant Age Related Macular Degeneration Drug Market Share (2012-2017) Table Allergan Basic Information, Manufacturing Base, Production Area and Its Competitors Table Allergan Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) Table Allergan Age Related Macular Degeneration Drug Market Share (2012-2017) Table Alimera Sciences Basic Information, Manufacturing Base, Production Area and Its Competitors Table Alimera Sciences Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) Table Alimera Sciences Age Related Macular Degeneration Drug Market Share (2012-2017) Table Ophthotech Basic Information, Manufacturing Base, Production Area and Its Competitors Table Ophthotech Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) Table Ophthotech Age Related Macular Degeneration Drug Market Share (2012-2017) Table Acucela Basic Information, Manufacturing Base, Production Area and Its Competitors Table Acucela Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2012-2017) Table Acucela Age Related Macular Degeneration Drug Market Share (2012-2017) … Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Age Related Macular Degeneration Drug Figure Manufacturing Process Analysis of Age Related Macular Degeneration Drug Figure Age Related Macular Degeneration Drug Industrial Chain Analysis Table Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2015 Table Major Buyers of Age Related Macular Degeneration Drug Table Distributors/Traders List Figure Global Age Related Macular Degeneration Drug Production and Growth Rate Forecast (2017-2021) Figure Global Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast (2017-2021) Table Global Age Related Macular Degeneration Drug Production Forecast by Regions (2017-2021) Table Global Age Related Macular Degeneration Drug Consumption Forecast by Regions (2017-2021) Table Global Age Related Macular Degeneration Drug Production Forecast by Type (2017-2021) Table Global Age Related Macular Degeneration Drug Consumption Forecast by Application (2017-2021)

Roche/Genentech Novartis Regeneron Bayer Valeant Allergan Alimera Sciences Ophthotech Acucela Ohr Pharmaceuticals